MedTrace Logo

TactiCath® Prospective Effectiveness Pilot Study

NCT02131337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-01-30

No results posted yet for this study

Summary

EFFICAS II proposes to test the hypothesis that treatment efficacy correlates to contact force parameters applied for pulmonary vein isolation (PVI) during AF ablation.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

OTHER

Electrophysiology study

after 3 months to check for pulmonary vein isolation (PVI) status

Sponsors & Collaborators

  • Endosense

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Czechia
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131337 on ClinicalTrials.gov